Please login to the form below

Not currently logged in

Takeda considers India deals, says report

India's the Economic Times has reported that Takeda is holding talks with India-based generic drug firms Cipla and Lupin

Takeda Pharmaceutical Company is reportedly in takeover talks with India-based generic drug manufacturers Cipla and Lupin, according to the Economic Times.

Takeda, which has said it wants to expand in India, one of the world's fastest growing drug markets, has reportedly held preliminary talks with Cipla, while talks with Lupin have progressed beyond the initial stage.

The newspaper, which cited individuals with direct knowledge of the development, could not confirm the story with official representatives of the companies. It did, however, quote a Cipla spokeswoman: "We would like to clarify that these reports are baseless and untrue and is categorically denied."

The Economic Times said that Takeda was interested in buying Lupin's domestic formulations business, as well as its research facility, but its founders were not willing to sell the research unit.

The speculation follows news that Sanofi is to expand its role in India with the acquisition of Universal Healthcare's over-the-counter business unit.

For more information about the fast-growing pharmaceutical industry in India, see PMGroup's Country Report: India.

24th August 2011


Featured jobs

Subscribe to our email news alerts


Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?